will be a mutibagger
pretty darn cheap here
Celladon Shares May Have Upside to $70
The developer of gene therapy for heart failure to announce pivotal trial results.
ZIOP partners with Md Anderson Cancer Center, Major Biotech XON I think that's why he's saying that.
Or Google 81%
CYBR Accelerating Revenue 81% Year-Over-Year